In parallel, MSCs treatment inhibited hyperglycemia-induced increase in Drp1 levels in rat aortas (Fig. 9b, a) but exerted no effect on the expression of OPA1, MFN2 and Fis1 (Fig. 9b, b–d). Here, OPA1 is linked to Hyperglycemia.